Daily Star on MSN7h
'I'm an Olympic hero with multiple sclerosis – you can continue living life to the best'
Lina Nielsen was diagnosed with MS aged 17 and initially feared her athletics dreams were over due to her lack of education ...
Hosted on MSN23h
Metastasis-Directed Therapy for Prostate Cancer a Clear Winner in Meta-Analysis
Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...
pharmaphorum23h
Sanofi builds case for Sarclisa, challenging J&J’s Darzalex
Sanofi is trumpeting new data for its anti-CD38 drug Sarclisa as it tries to capture market share from Johnson & Johnson’s blockbuster Darzalex in the multiple myeloma market. A couple of months ...
Johnson & Johnson to resume U.S. Varipulse cases after safety review
Johnson & Johnson (JNJ) stock in focus as limited rollout of Varipulse heart device resumes after a safety review prompted by ...
The Pharma Letter7h
Allogene leaps on allogeneic CAR-T therapy success
Shares of US clinical-stage biotech Allogene Therapeutics rocketed 41% to $1.99 on Friday, as it announced the publication of ...
The Pharma Letter7h
EC approves CSL and Arcturus’ Kostaive
The European Commission has granted marketing authorization for Kostaive (ARCT-154), a self-amplifying mRNA COVID-19 vaccine, ...
The Lancet22h
Sodium–glucose co-transporter inhibitors—who would have guessed?
Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have ...
Medindia11h
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...